CD4 and neoplasm: This is consistent with a recent study of human ovarian tumors using similar markers (CD3, CD4, CD8, and CD20) which showed that tumor infiltrating lymphocytes were more prevalent in high-grade serous carcinomas followed by endometrioid ovarian tumors and then other ovarian tumor types [6].